2 Healthcare Stocks That Could Double Your Money
Should you be as excited as the analysts who think these stocks are two-baggers in the making?
MannKind Corporation
MNKD
MNKD
$1.18
-$0.04
0.0%
BATS BZX Real Time Price as of May 24, 2019, 3:34 p.m.
View Interactive MNKD Charts
MannKind Corporation
News & Analysis: MannKind Corporation
The Fool has written over 100 articles on MannKind Corporation.
All
Market Moves
Earnings
Why MannKind Is Up Big Today
Shares rise after the company receives some praise from a pair of Wall Street analysts.
MannKind Corporation (MNKD) Q1 2019 Earnings Call Transcript
MNKD earnings call for the period ending March 31, 2019.
MannKind Corp (MNKD) Q4 2018 Earnings Conference Call Transcript
MNKD earnings call for the period ending December 31, 2018.
Here's Why MannKind Rocketed Higher Today
Shares jumped after the company reported upbeat fourth-quarter results. Here's what investors need to know.
Why MannKind Stock Is Plunging Today
Shares tumble after the biopharma raises capital from a dilutive common-stock offering.
Why MannKind Corp. Soared 16.4% Tuesday
The company has completed its planned transaction with United Therapeutics.
Here's What Sent MannKind Corporation Soaring 66.4% in September
A new collaboration agreement breathed life into the troubled manufacturer of inhaled insulin powder.
MannKind Stock History
Here's the full story of how this biopharma got to where it is today.
Is MannKind Corporation Stock a Buy?
A new collaboration is funneling tens of millions of dollars onto the diabetes company’s balance sheet.
